Supplier Type
- Manufacturer
- Trader
- Reagent
- contract manufacturer
- custom synthesis
Supplier Region
- New Delhi(2)
- Maharashtra(9)
- Beijing(1)
- Gujarat(9)
- Hyderabad(23)
- Bangalore(3)
- Mumbai(11)
- Andhra Pradesh(3)
- Ahmedabad(1)
- Delhi(3)
- Telangana(2)
- Tamil Nadu(1)
- Pune(1)
- Karnataka(2)
Purity
- NLT 95%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- ABOVE 99%
- 99.90%
- 99.9%
- 99.89%
- 99.86%
- 99.80%
- 99.71%
- 99.20%
- 99.04%
- 99%
- 98+
- 98.93%
- 98.80%
- 98.62%
- 98.00%
- >98%
- 98%
- 97-99%
- 97.98%
- 97.60%
- 97.00%
- >97%
- 97%
- 97 %
- 95.93%
- 95.69%
- 95.60%
- 95.00%
- 90 % Above
- 0.5M
Package
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 1g
- 5g
- 10g
- 25g
- 50g
- 100ml
- 100g
- 500g
- 500ml
- 1L
- 5kg
- 25kg
- 50kg
- 100kg
- 250kg
- 500kg
- 1MT
- 1and gm
- 250250 mg.
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 1kg
- 10kg
-
Dapagliflozin
461432-26-8
-
Dapagliflozin Propanediol
1971128-01-4
-
ETHYL DAPAGLIFLOZIN
-
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1R)-
1373321-04-0
-
Dapagliflozin Tetraacetate
461432-25-7
-
10mg Dapagliflozin Tablets -
Ortho-Isomer of Dapagliflozin
2040305-05-1
-
Dapagliflozin propanediol monohydrate
960404-48-2
-
Dapagliflozin Impurity 3 -
Dapagliflozin Impurity 10
960404-86-8
R-5-(Azidomethyl)-3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxazolidinone 168828-84-0
(R)-[3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl methanesulfonate 174649-09-3
7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 86393-33-1
2-Fluoro-4-Methylaniline CAS No 452-80-2, Grade Standard: Reagent Grade 452-80-2
5(R)-Hydroxymethyl-3-[3-fluoro-4-(4-morpholinyl)phenyl]oxazolidin-2-one 168828-82-8
7-Chloro-1-Cyclopropyl-6-Fluoro- 1,4,Dihydro-4-Oxo-Quinoline-3- Carboxylic Acid 86393-33-1
Powder 2,3-Di-O-Acetyl-5-Deoxy-5 Fluoro Cytidine (Cas No:161599-46-8) 161599-46-8
N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine 1421372-94-2
